NeuroPace (NPCE) Retained Earnings (2020 - 2026)
NeuroPace's (NPCE) quarterly Retained Earnings came in at $573.5 million in Q1 2026, up 206.69% year-on-year from $187.0 million in Q1 2025, and little changed quarter-over-quarter from $571.4 million in Q4 2025.
NeuroPace (NPCE) Retained Earnings (2020 - 2026) Analysis & Trends
NeuroPace's Retained Earnings history runs 7 years deep, the most recent figure standing at $573.5 million for Q1 2026.
- On a quarterly basis, Retained Earnings rose 206.69% year-over-year to $573.5 million in Q1 2026; TTM through Mar 2026 was $573.5 million, a 206.69% increase from a year earlier, with the FY2025 full-year figure at $571.4 million, up 207.62% from the prior year.
- Retained Earnings held at $573.5 million in Q1 2026 per NPCE's latest filing, from $571.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $573.5 million in Q1 2026 and bottomed at -$546.2 million in Q2 2025.
- The 5-year median for Retained Earnings is -$465.3 million (2022), against an average of -$84.2 million.
- Across the five-year window, Retained Earnings soared 51901.73% in 2023 and plunged 201.24% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$470.9 million in 2022, then soared by 211.38% to $524.4 million in 2023, then plunged by 201.24% to -$530.9 million in 2024, then soared by 207.62% to $571.4 million in 2025, then gained by 0.37% to $573.5 million in 2026.
- Per Business Quant, the three latest NPCE Retained Earnings figures stand at $573.5 million (Q1 2026), $571.4 million (Q4 2025), and $568.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 573.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 573.52 Mn |
| Dec 31, 2025 | 571.41 Mn |
| Sep 30, 2025 | 568.17 Mn |
| Jun 30, 2025 | -546.20 Mn |
| Mar 31, 2025 | -537.54 Mn |
| Dec 31, 2024 | -530.95 Mn |
| Sep 30, 2024 | -525.70 Mn |
| Jun 30, 2024 | -520.20 Mn |
| Mar 31, 2024 | -512.70 Mn |
| Dec 31, 2023 | 524.44 Mn |
| Jun 30, 2023 | -490.40 Mn |
| Mar 31, 2023 | 508.69 Mn |
| Dec 31, 2022 | -470.85 Mn |
| Sep 30, 2022 | -459.70 Mn |
| Jun 30, 2022 | 502.25 Mn |
| Mar 31, 2022 | -982,000.00 |
| Dec 31, 2021 | -423.77 Mn |
| Sep 30, 2021 | 494.73 Mn |
| Jun 30, 2021 | -405.00 Mn |
| Mar 31, 2021 | 240.03 Mn |